CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-27 | Alland Leila Director | Sale | −7,246 | $3.90 | $28K | 71,857 |
| 2023-09-27 | Seshadri Vishwas Chief Executive Officer | Purchase | +20,000 | $4.07 | $81K | 521,731 |
| 2023-09-21 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −563 | $3.80 | $2K | 186,858 |
| 2023-09-20 | Amoroso Michael Director | Sale | −327 | $3.90 | $1K | 114,465 |
| 2023-09-19 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +14 | $3.70 | $52 | 235,193 |
| 2023-09-19 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +2,986 | $3.82 | $11K | 238,179 |
| 2023-09-18 | O'Malley Brendan M. SVP, General Counsel | Purchase | +3,000 | $3.80 | $11K | 187,421 |
| 2023-07-24 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −1,187 | $3.73 | $4K | 235,179 |
| 2023-06-20 | Amoroso Michael Director | Sale | −338 | $4.45 | $2K | 114,792 |
| 2023-06-14 | Amoroso Michael Director | Grant or award | +58,689 | $4.62 | $271K | 115,130 |
| 2023-06-14 | Alvino Mark Director | Grant or award | +58,689 | $4.62 | $271K | 76,216 |
| 2023-06-14 | Alland Leila Director | Grant or award | +58,689 | $4.62 | $271K | 79,103 |
| 2023-06-14 | Charles Faith L. Director | Grant or award | +58,689 | $4.62 | $271K | 79,103 |
| 2023-06-14 | Wuchterl Donald A. Director | Grant or award | +58,689 | $4.62 | $271K | 79,103 |
| 2023-06-14 | Silverstein Christine Berni Director | Grant or award | +58,689 | $4.62 | $271K | 94,214 |
| 2023-06-05 | Seshadri Vishwas Chief Executive Officer | Grant or award | +336,826 | 501,731 | ||
| 2023-06-05 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +141,908 | 236,366 | ||
| 2023-06-05 | O'Malley Brendan M. SVP, General Counsel | Grant or award | +90,902 | 184,421 | ||
| 2023-06-02 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −827 | $3.06 | $3K | 164,905 |
| 2023-04-25 | Alvino Mark Director | Sale | −887 | $3.25 | $3K | 17,527 |
Page 8 of 12 · 223 trades